Loading clinical trials...
Loading clinical trials...
This is a multicenter, single-arm, open-label study to characterize long-term safety and tolerability of MY008211A tablets and to provide access to MY008211A tablets to patients with PNH who have comp...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wuhan Createrna Science and Technology Co., Ltd
NCT03520647 · Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), and more
NCT05876312 · Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT06312644 · Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, and more
NCT07152288 · Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT06294301 · Paroxysmal Nocturnal Hemoglobinuria (PNH)
Chinese Academy of Medical Sciences Hematology Hospital (Institute of Hematology, Chinese Academy of Medical Sciences)
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions